Diagnostic News and Research

RSS

Recent releases in Global Health

A Lancet Infectious Diseases editorial describes the growing public concerns over a global rise in antimicrobial resistance. "Bearing in mind that our objective is to contain antibiotic resistance rather than eradicate it, several policies could be adopted to help guarantee a future for antibiotics," the editorial states, adding, "We need reliable data to tackle antibiotic resistance.

2 Apr 2011

Elmhurst Memorial Healthcare chooses Merge Cardio, Merge Hemo for new facility

Merge Healthcare Incorporated, a global corporation dedicated to health IT interoperability solutions, today announced that Elmhurst Memorial Healthcare, a 600-physician healthcare system based in Elmhurst, Illinois, selected Merge Cardio and Merge Hemo for their new 259-bed hospital.

2 Apr 2011

BC Psychological Association cautions against expanded gambling

Committed to promoting mental health in BC communities, the BC Psychological Association would like to address the current proposal put forth for a Casino expansion in downtown Vancouver:

2 Apr 2011

South Africa, Lesotho, Swaziland form alliance to fight MDR-TB

Health ministers from Lesotho, Swaziland and South Africa said they have formed an alliance to fight drug-resistant tuberculosis, Deutsche Presse-Agentur/M&C reports.

1 Apr 2011

3M announces acquisition of Zargis Medical assets

3M announced today it has acquired certain assets of Zargis Medical Corp., maker of the only FDA-approved diagnostic software to classify suspected systolic and diastolic heart murmurs.

1 Apr 2011

New Mexico Software annual revenue decreases 5% to $3.48 million

New Mexico Software, Inc. announced today its financial results, reporting annual revenue in 2010 decreased approximately 5% to $3.48 million compared to $3.66 million in 2009.

1 Apr 2011

Scientists develop new experimental diagnostic test to distinguish infection from disease

A potential new experimental diagnostic test able to quickly distinguish individuals with active tuberculosis from those with latent TB infection has been developed. If the preliminary results of the study will be confirmed in a larger population sample, the new diagnostic system could allow more effective strategies to control the spread of the re-emerging pathology.

1 Apr 2011

PGXL to utilize AutoGenomics' automated INFINITI analyzer for personalized medicine applications

PGXL Labs, an internationally recognized pioneer in personalized medicine testing, announced today that it has established a collaborative partnership with AutoGenomics, Inc. wherein they will utilize the automated INFINITI® analyzer for several different personalized medicine applications.

1 Apr 2011

Analysis of non-tumor tissue may be an effective option for diagnosis of prostate cancer

Researchers have found that it may not be necessary to look for tumors directly in patients with prostate cancer - analyzing non-tumor tissue may be an effective option, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.

1 Apr 2011

Oncology experts educate lawmakers about latest information on radiation therapy

Leaders from the radiation oncology community – representing patients, physicians, providers, and manufacturers – met on Capitol Hill today to educate lawmakers and their staffs about the latest in radiation therapy technologies and techniques, improvements in patient care and the community's focus on patient safety in radiation therapy delivery.

1 Apr 2011

IOVS journal publishes first global consensus report on MGD

The first global consensus report on meibomian gland dysfunction - a major cause of lid disease and evaporative dry eye - has been published in a special issue of the Investigative Ophthalmology & Visual Science journal.

1 Apr 2011

Positive outcome from Orexo's OX51 initial pharmacokinetic trial to treat acute intensive pain

Orexo AB announces the positive outcome following completion of the initial pharmacokinetic trial in the OX51 project. The project is aimed at developing a sublingual dosage form tailored to treat acute intensive pain episodes in relation to care-related diagnostic or therapeutic procedures for patients whom are not receiving sufficient pain relief.

1 Apr 2011

Mitomics introduces new test to detect prostate cancer

Mitomics, world leader in the research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today the launch of its flagship product, the Prostate Core Mitomic Test, a revolutionary new test that uses the science of mitochondrial DNA to accurately determine the absence or presence of cancerous cells using previously obtained prostate biopsy tissue.

1 Apr 2011

Catheter-related bloodstream infections in children

Hospitals can reduce the risk of life-threatening bloodstream infections in children with peripherally inserted central venous catheters by assessing daily the patient’s progress and removing the device as early as possible, according to a new Johns Hopkins Children’s Center study published online March 31 in the journal Clinical Infectious Diseases.

31 Mar 2011

Adeona reports $3,164,512 net revenue for 2010

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, reported its financial results for the year ended December 31, 2010, as well as updates since the beginning of the 4th quarter.

31 Mar 2011

Foundation for nationwide consensus on access to genetic information

Health privacy is a serious concern, but as genetic testing becomes more common, access to your genetic information raises questions the healthcare industry has never faced before. It is particularly important that we begin to address these questions now that genomic information is being collected to improve the diagnosis and treatment of children.

31 Mar 2011

Experts discuss about need for national colorectal cancer screening program at Capitol Hill

On Capitol Hill today, colorectal cancer experts and advocates will gather to promote the establishment of a national colorectal cancer screening program in an effort to save lives.

From Evident Corporation - Life Sciences 31 Mar 2011

Top-line results from Biomoda's CyPath pilot study against lung cancer

Cancer diagnostics company Biomoda, Inc. today announced top-line results of its pilot study for lung cancer which shows highly significant evidence of CyPath's ability to discriminate between cancer and non-cancer groups based on sputum samples collected in a non-invasive manner.

31 Mar 2011

Regular CT scans can cause secondary malignancies in older men with testicular cancer

UC Davis cancer researchers have found that older men with early-stage testicular cancer who opt for surveillance with regular CT scans over lymph node removal are at greater risk for secondary cancers.

31 Mar 2011

KSB, SuperNova sign agreement to develop and commercialize Neopterin

SuperNova Diagnostics, a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology, a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets for the research, development, manufacture and commercialisation of diagnostic products and services for the measurement of Neopterin, its metabolites and derivatives utilising the SuperNova technology platform of AmpCrystal.

31 Mar 2011